Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.5389
+0.0389 (7.78%)
At close: Jun 22, 2026, 4:00 PM EDT
0.5728
+0.0339 (6.29%)
Pre-market: Jun 23, 2026, 7:54 AM EDT
Pasithea Therapeutics Employees
Pasithea Therapeutics had 5 employees as of December 31, 2025. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$3,946,785
Market Cap
18.01M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | 1 | 25.00% | 5 | 0 |
| Dec 31, 2024 | 4 | -4 | -50.00% | 4 | 0 |
| Dec 31, 2023 | 8 | -7 | -46.67% | 8 | 0 |
| Dec 31, 2022 | 15 | 10 | 200.00% | 15 | 0 |
| Dec 31, 2021 | 5 | 2 | 66.67% | 3 | 2 |
| Jun 30, 2021 | 3 | - | - | 1 | 2 |
| Mar 31, 2021 | 3 | - | - | 1 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Werewolf Therapeutics | 39 |
| Lunai Bioworks | 29 |
| Passage Bio | 24 |
| Moleculin Biotech | 17 |
| Lipocine | 14 |
| NewcelX | 12 |
| AEON Biopharma | 8 |
| Tempest Therapeutics | 5 |
KTTA News
- 7 days ago - Pasithea Therapeutics announces amendments to PAS-004 clinical study - TheFly
- 7 days ago - Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial - GlobeNewsWire
- 8 days ago - Pasithea Therapeutics Announces Exhibit at Children's Tumor Foundation 2026 NF Conference - GlobeNewsWire
- 21 days ago - Pasithea Therapeutics granted Orphan Drug Designation for PAS-004 by FDA - TheFly
- 21 days ago - Pasithea Therapeutics Announces Orphan Drug Designation by FDA of PAS-004 for Treatment of Amyotrophic Lateral Sclerosis (ALS) - GlobeNewsWire
- 24 days ago - Pasithea gets orphan status for treatment of amyotrophic lateral sclerosis - TheFly
- 7 weeks ago - Pasithea Therapeutics appoints Kartik Krishnan as chief medical officer - TheFly
- 7 weeks ago - Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer - GlobeNewsWire